September 16 coronavirus news

By Nectar Gan, Adam Renton, Meg Wagner, Melissa Macaya, Ed Upright and Jack Guy, CNN

Updated 12:51 a.m. ET, September 17, 2020
43 Posts
Sort byDropdown arrow
1:49 p.m. ET, September 16, 2020

Florida reports 195 new Covid-19 cases among children

From CNN's Melissa Alonso  

Florida health officials reported 195 new pediatric Covid-19 cases on Wednesday, according to the Florida Department of Health (DOH).  

DOH reported one new pediatric hospitalization related to coronavirus, bringing the total number of children that have been hospitalized due to the virus to 688. 

To date there have been 54,849 cases of coronavirus among children in Florida, DOH data shows.

The positivity rate among children in Florida is currently 14%, DOH data shows. 

The age group for pediatric cases is 0-17 years old.

1:31 p.m. ET, September 16, 2020

HHS spokesperson Michael Caputo to take a leave of absence

From CNN's Sam Fossum

Michael Caputo arrives at the Hart Senate Office building to be interviewed by Senate Intelligence Committee staffers on May 1, 2018 in Washington.
Michael Caputo arrives at the Hart Senate Office building to be interviewed by Senate Intelligence Committee staffers on May 1, 2018 in Washington. Mark Wilson/Getty Images

Health and Human Services' assistant secretary for public affairs Michael Caputo will take a 60-day leave of absence, according to a news release from the department. 

"Today, the Department of Health and Human Services is announcing that HHS Assistant Secretary for Public Affairs Michael Caputo has decided to take a leave of absence to focus on his health and the well-being of his family. Mr. Caputo will be on leave for the next 60 days," the HHS statement reads. 

The announcement comes after Caputo apologized to staffers on Tuesday for a conspiracy-laden rant in which he accused government scientists of "sedition" and of working to undermine the President.

As CNN has also previously reported, Caputo is dealing with potential health issues. 

1:30 p.m. ET, September 16, 2020

CDC to update its confusing guidance about testing people without Covid-19 symptoms, Redfield says

From CNN's Maggie Fox

 

Director Dr. Robert Redfield holds up a CDC document while he speaks at a hearing of the Senate Appropriations subcommittee reviewing coronavirus response efforts on Wednesday in Washington.
Director Dr. Robert Redfield holds up a CDC document while he speaks at a hearing of the Senate Appropriations subcommittee reviewing coronavirus response efforts on Wednesday in Washington. Andrew Harnik/Pool/Getty Images

The US Centers for Disease Control and Prevention is set to “clarify” confusing and controversial changes made to its guidance about testing people who do not have symptoms of coronavirus, CDC Director Dr. Robert Redfield said Wednesday.

“We are working on a clarification document related to the diagnostic and public health use of testing,” Redfield told a hearing of the Senate Appropriations Committee.

“We have never recommended against asymptomatic testing. You’ll see in the clarification we are making it very clear asymptomatic and presymptomatic transmission is important, and making it very clear if you have been exposed to somebody, you need to be tested and contact traced,” Redfield added.

Testing guidelines were changed on CDC’s site quietly, without public notice, on Aug. 24. 

Here’s what the CDC website said previously: “Testing is recommended for all close contacts of persons with SARS-CoV-2 infection. Because of the potential for asymptomatic and pre-symptomatic transmission, it is important that contacts of individuals with SARS-CoV-2 infection be quickly identified and tested.” 

The site was changed on Aug. 24 to say: “If you have been in close contact (within 6 feet) of a person with a COVID-19 infection for at least 15 minutes but do not have symptoms, you do not necessarily need a test unless you are a vulnerable individual or your health care provider or State or local public health officials recommend you take one.” 

Redfield said the agency would post new guidance updating those changes, which were broadly denounced by public health experts. “We are going to come out with that hopefully, I hope before the end of the week,” Redfield told the hearing.

He said testing is important not only for diagnosing cases, but for screening groups to find cases that are not obvious. “Screening can be very powerful,” he said. It can help schools reopen and help people get back to more normal lives, he added.

Now that more tests are available, Redfield said, the CDC will also encourage surveillance testing, which can help find cases that might otherwise go unnoticed until an outbreak has started.

 

1:31 p.m. ET, September 16, 2020

Floridan Covid-19 deaths near 13,000, state reports

From CNN's Melissa Alonso  

Florida health officials reported 152 resident deaths on Wednesday, bringing the resident death toll to 12,939, according to the Florida Department of Health (DOH).  

Florida health officials report 161 non-Florida resident deaths in the state as well, DOH data shows.

DOH reported 2,355 new cases of Covid-19, bringing the state’s total to 671,201.

Note: These numbers were released by Florida’s public health agency, and may not line up exactly in real time with CNN’s database drawn from Johns Hopkins University and the Covid Tracking Project   

1:27 p.m. ET, September 16, 2020

Documents outline federal government plans to distribute free Covid-19 vaccines

From CNN's Jamie Gumbrecht

Sandra Rodriguez, 63, receives a Covid-19 vaccination from Yaquelin De La Cruz at the Research Centers of America in Hollywood, Florida, on August 13.
Sandra Rodriguez, 63, receives a Covid-19 vaccination from Yaquelin De La Cruz at the Research Centers of America in Hollywood, Florida, on August 13. Chandan Khanna/AFP/Getty Images

Federal documents released Wednesday provide new details about the government’s plan to distribute Covid-19 vaccines for free once approved or authorized for emergency use by the US Food and Drug Administration. 

“We’re dealing in a world of great uncertainty,” Paul Mango, deputy chief of staff for policy at the US Department of Health Human Services, said during a briefing with reporters on Wednesday. “We don't know the timing of when we'll have a vaccine. We don't know the quantities. We don't know the efficacy of those vaccines.” 

He noted that vaccines being tested have different transport and storage requirement; some require a second dose at 21 or 28 days after the first; and some require different needles and syringes.

“I think the message we want you to leave with is we are prepared for all of those uncertainties,” Mango said. 

Here are key things to know about the plan:

Limited early supply

A US Centers for Disease Control and Prevention vaccine distribution playbook says that for planning purposes, state and local health agencies should assume “limited COVID-19 vaccine doses may be available by early November 2020” if a vaccine is authorized or licensed by the FDA, but the supply may increase substantially in 2021. The initial supply is expected to go to health care workers, other essential workers and people at higher risk for severe illness from Covid-19. 

The US Department of Defense, CDC and some parts of HHS are coordinating the supply, production and distribution of vaccines. Vaccine administration sites may be limited early on to target particular populations and storage requirements. Later on, sites could expand to include pediatric and adult health care providers and pharmacies. 

IT infrastructure

The effort requires extensive data monitoring to track vaccines, handle claims and payment, identify who needs a second a dose and to monitor outcomes and potential adverse events. Operation Warp Speed will construct and integrate IT architecture to meet these needs, according to the strategy document.

Lt. Gen. Paul Ostrowski from Operation Warp Speed said during the briefing Wednesday that databases to track vaccines already exist at state and pharmacy levels. “The hard part is being able to get the databases to talk with one another,” he said, for example, so that he could get a vaccine at a public health center and then get the correct second dose weeks later, perhaps at a pharmacy in a different location. 

Cost

On cost, the distribution strategy says the objective is “to ensure no one desiring vaccination will face an economic barrier to receiving one.”

“The federal government is procuring hundreds of millions of doses of safe and effective vaccines, and has contracted with McKesson for purposes of vaccine distribution, such that no American will be charged for either the COVID-19 vaccine or its distribution,” the strategy document says. 

Vaccine information campaign

The strategy document says an information campaign led by HHS public affairs “will focus on vaccine safety and efficacy, and target key populations and communities to ensure maximum vaccine acceptance.” 

“Identifying the right messages to promote vaccine confidence, countering misinformation, and targeting outreach to vulnerable and at-risk populations will be necessary to achieve high coverage,” it says.

1:22 p.m. ET, September 16, 2020

A mask may provide better protection against Covid-19 than a vaccine, CDC director says

From CNN's Andrea Diaz

Centers for Disease Control and Prevention Director Dr. Robert Redfield speaks at a hearing of the Senate Appropriations subcommittee reviewing coronavirus response efforts on September 16 in Washington, DC. 
Centers for Disease Control and Prevention Director Dr. Robert Redfield speaks at a hearing of the Senate Appropriations subcommittee reviewing coronavirus response efforts on September 16 in Washington, DC.  Andrew Harnik/Pool/Getty Images

Wearing a face mask might provide better protection against Covid-19 than a vaccine, Dr. Robert Redfield, director of the US Centers for Disease Control and Prevention, said during Wednesday's Senate Appropriations subcommittee hearing.

"I might even go so far as to say that this face mask is more guaranteed to protect me against Covid than when I take a Covid vaccine, because the immunogenicity may be 70% and if I don't get an immune response, the vaccine is not going to protect me. This face mask will," Redfield explained, adding that the American public has not yet embraced the use of face masks to a level that could effectively control the outbreak.

"So I do want to keep asking the American public to take the responsibility, particularly the 18 to 25 year olds where we're seeing the outbreak in America continue to go like this," Redfield said.

Watch:

12:31 p.m. ET, September 16, 2020

CDC director says Covid-19 vaccine for general public likely to be available in 2021

From CNN’s Naomi Thomas

Centers for Disease Control and Prevention Director Dr. Robert Redfield attends a hearing of the Senate Appropriations subcommittee reviewing coronavirus response efforts on September 16 in Washington, DC. 
Centers for Disease Control and Prevention Director Dr. Robert Redfield attends a hearing of the Senate Appropriations subcommittee reviewing coronavirus response efforts on September 16 in Washington, DC.  Andrew Harnik/Pool/Getty Images

Dr. Robert Redfield, director of the US Centers for Disease Control and Prevention, said during a Senate Appropriations subcommittee hearing on Wednesday that he thinks it will be the late second quarter or third quarter of 2021 before a Covid-19 vaccine is generally available to the American public. 

When asked when he thought there would be a vaccine ready to administer to the American public, Redfield said he thought that there would be vaccine initially available sometime between November and December, but “very limited supply and will have to be prioritized.” 

“If you’re asking me when is it going to be generally available to the American public, so we can begin to take advantage of vaccine to get back to our regular life, I think we’re probably looking at third, late second quarter, third quarter 2021.” 

Redfield said that he thought the vaccination would begin in November and December “and then will pick up, and it will be in a prioritized way. It will be those first responders and those at greatest risk for death, and then eventually that will expand.” 

Watch:

11:56 a.m. ET, September 16, 2020

Pac-12 commissioner says conference is still not ready for football to return

From CNN's David Close

Pac-12 Commissioner Larry Scott speaks at a pre-game press conference at Levi's Stadium on December 6, 2019, in Santa Clara, California.
Pac-12 Commissioner Larry Scott speaks at a pre-game press conference at Levi's Stadium on December 6, 2019, in Santa Clara, California. Alika Jenner/Getty Images

On the day the Big Ten conference announced a return plan for a fall football season, Pac-12 commissioner Larry Scott released a statement noting the conference still has significant issues to solve before considering its own return to play. 

Scott sites health restrictions currently in place in California and Oregon that prevent football teams from practicing. There are six Pac-12 universities in those states. Scott also hints to concerns regarding the poor air quality created from the wildfires raging in the western United States. 

The Pac-12 remains the lone Power 5 conference that does not have a plan in place to play football this fall. 

Here's the statement from the commissioner:

"At this time, our universities in California and Oregon do not have approval from state or local public health officials to start contact practice. We are hopeful that our new daily testing capability can help satisfy public health official approvals in California and Oregon to begin contact practice and competition. We are equally closely monitoring the devastating fires and air quality in our region at this time. We are eager for our student-athletes to have the opportunity to play this season, as soon as it can be done safely and in accordance with public health authority approvals."

11:48 a.m. ET, September 16, 2020

N95 mask makers are still struggling to meet the demand, 3M CEO says

From CNN's Aditi Sangal

3M is a company known for scotch tapes and post-it notes but during the coronavirus pandemic, it has become the largest producer of N95 masks. However, even as the company ramped up production and is on its way to produce 95 million masks a month this fall and 2 billion by the end of 2020, it’s still facing a challenge to meet the demand for the masks, CEO Mike Roman says.

“Even today, the demand for N95s is greater than not only our production capacity, but the entire industry. So we're still facing a challenge to meet that demand,” he told CNN Wednesday.

“We are working in partnership with other companies to look at ways that you can reuse N95s. We're also exploring ways to bring other kinds of respiratory solutions. We have reusable respirators, which are another solution. They can't meet all of the demand either but there are other things we're doing to fight them at every angle,” he added.

A lesson already being learned from this pandemic and production process is that investing in inventory and capacity is key.

“It's public-private partnerships that are doing that. Part of the investment with the DoD is to be able to have capacity to build an inventory of N95s. It’s also true that we’re doing that in partnership with health care providers, making sure that they have sufficient inventory.”

“Broadly, we were not ready for the demand,” he told CNN about pandemic preparedness at the beginning of the coronavirus crisis.